Article
Treating low HDL--from bench to bedside.
Clinical biochemistry - 1 Aug 2004
Ng Dominic S
Abstract excerpt
The inverse relationship between the plasma high-density lipoprotein cholesterol (HDL-C) and the risk of coronary heart disease (CHD) is well recognized in the general population. However, the development of effective therapeutics targeting HDL continues to be challenging, which is due in part to the heterogeneity of its structure and composition and the complexity of its metabolism. In this paper, we review a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
